• Profile
Close

Older adult patients use more aminosalicylate monotherapy compared with younger patients with inflammatory bowel disease: TARGET-IBD

Journal of Clinical Gastroenterology Jun 22, 2021

Barnes EL, Hanson JS, Regueiro MD, et al. - Researchers conducted the study for describing medication utilization patterns in older inflammatory bowel disease (IBD) patients. Data were obtained from the 34 sites in TARGET-IBD, a multicenter, observational cohort. Pairwise comparisons were used to examine therapy use, and multivariable logistic regression models were used to assess the odds of IBD-specific therapy use among patients over the age of 65. Participants in the study were 2,980 patients with IBD. When compared with younger age groups, older IBD patients use much more aminosalicylate monotherapy and less anti-tumor necrosis factor monotherapy. Given the United States' aging population, these utilization patterns may have long-term implications for disease control.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay